Dec/09
19
Stocks zigzag as options contracts expire; Tech profits boost hopes for revenue growth
0 Comments | Posted by admin in Stem Cell Therapy, Stem Cells
more images
more images
Stocks trade mixed as options contracts expire
NEW YORK — The stock market drifted Friday as traders did some quarterly housekeeping and moved into technology stocks after two of the industry’s big names said business was improving.
After a volatile morning, the market began to settle out in the afternoon as more investors looked to …. Read the original article : here.
No comments yet.
Leave a comment!
You must be logged in to post a comment.
« Umbilical cord could be new source of plentiful stem cells, say Pitt researchers
